Brief: Orchard Therapeutics Announces Regulatory And Clinical Updates For Lead Gene Therapy Programs

Orchard Therapeutics

29/06/2021 12:18

June 29 (Reuters) - Orchard Therapeutics PLC  ORTX.O :
    * ORCHARD THERAPEUTICS ANNOUNCES REGULATORY AND CLINICAL
UPDATES
FOR LEAD GENE THERAPY PROGRAMS
    * ORCHARD THERAPEUTICS PLC - EXPECTED CLINICAL PACKAGE FOR
OTL-200
BLA FOR MLD USING DATA FROM EXISTING PATIENTS CLARIFIED WITH FDA
    * ORCHARD THERAPEUTICS PLC - GUIDANCE OBTAINED ON DESIGN OF
OTL-203 GLOBAL REGISTRATIONAL TRIAL FOR MPS-IH
    * ORCHARD THERAPEUTICS PLC - ENROLLMENT GOAL MET IN OTL-201
POC
TRIAL FOR MPS-IIIA
    * ORCHARD THERAPEUTICS PLC - UPDATES FOR OTL-103 MAA AND BLA
SUBMISSION TIMELINES FOR WAS
    * ORCHARD THERAPEUTICS - NOW EXPECTS MAA SUBMISSION TIMELINE
REGARDING OTL-103 FOR WAS TO SHIFT FROM 2021 TO 2022, SUBJECT TO
FURTHER DIALOGUE WITH EMA

Source text for Eikon:  ID:nGNXbl1tqN 
Further company coverage:  ORTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))